newsfilter
← Latest News
ACCESS Newswire·

With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation

LOS ANGELES, CALIFORNIA / ACCESS Newswire / February 10, 2026 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes transforming abundant feedstock into valuable nutraceuticals and new